Genotropin 5,3 mg Lyophilised powder and solvent for injection
PDF Leaflet Revision Date: 20 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Short stature due to growth hormone deficiency.
Dosage (summary)
0.5-0.7 IU/kg/week or 14-20 IU/m2/week; 1.0 IU/kg/week for Turner's Syndrome.
Special Populations
- Renal impairment
- Hypothyroidism
- Endocrine disorders
Pregnancy & Breastfeeding
Contraindicated during pregnancy and breastfeeding.
Key Drug Interactions
- Glucocorticoids
- Oral oestrogen therapy
Contraindications
- Hypersensitivity to somatropin
- Active tumor
- Closed epiphyses
Common side effects
- Injection site reaction
- Peripheral oedema
- Arthralgia
Counselling Points
- Rotate injection sites
- Monitor for signs of intracranial hypertension
- Report any severe headaches or visual changes
Serious warnings
- Monitor thyroid function
- Risk of hypoglycaemia and hyperglycaemia
Important Disclaimer
The Genotropin 5,3 mg Lyophilised powder and solvent for injection professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
